Pay in 4 interest-free payments of $6.30 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Pros: Well-documented safety profile
Patients currently using any GLP 1 medication should consult their healthcare provider before making changes as switching between products requires careful dose conversion and monitoring
[22] Tirzepatide (Mounjaro) has received NICE approval for type 2 diabetes and for weight management, again subject to specific eligibility criteria and specialist service requirements
However, the magnitude of impact for most of these agents to reverse iatrogenic weight gain tends to be modest, particularly once significant weight gain (ie, 7% of initial body weight) has already occurred
US$ 29.06
US$ 21.64
US$ 26.66
US$ 23.42
US$ 29.78
US$ 24.18
